LDA-SVM-Based EGFR Mutation Model for NSCLC Brain Metastases: An Observational Study

Epidermal growth factor receptor (EGFR) activating mutations are a predictor of tyrosine kinase inhibitor effectiveness in the treatment of non–small-cell lung cancer (NSCLC). The objective of this study is to build a model for predicting the EGFR mutation status of brain metastasis in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Nan, Wang, Ge, Wu, Yu-Hao, Chen, Shi-Feng, Liu, Guo-Dong, Chen, Chuan, Wang, Dong, He, Zhong-Shi, Yang, Xue-Qin, He, Yong, Xiao, Hua-Liang, Huang, Ding-De, Xiong, Kun-Lin, Wu, Yan, Huang, Ming, Yang, Zhen-Zhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602717/
https://www.ncbi.nlm.nih.gov/pubmed/25654374
http://dx.doi.org/10.1097/MD.0000000000000375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602717/
https://www.ncbi.nlm.nih.gov/pubmed/25654374
http://dx.doi.org/10.1097/MD.0000000000000375

Ejemplares similares